FundedIQ
Consumer Goods

eureciclo

eureciclo interfaces customer merchandise brands with recyclers, advancing reusing with social obligation. Through the eurecycle mark, we illuminate purchasers about organizations drew in with the environment,.encouraging more cognizant utilization. The eurecycle utilizes the natural pay model as an answer for invert planned operations. For this situation, natural pay comprises of discarding a mass of waste comparable to the mass of bundling that an organization puts available in an ecologically right way. For this, we endorse the administrators of assortment and arranging of recyclable waste and, through our mechanical stage, we really look at the consistency of the cycle in a versatile and safe manner. Then again, the connected with organizations produce motivations for the improvement of these administrators, demonstrate their interest in the reusing chain and, at last, get the eureciclo stamp to stamp their bundling and convey their obligation to buyers.

alias.eureciclo.com.br São Paulo, Brazil 101-250 employees
Total raised
$19.6M
Rounds
1
Latest
Series B
Jun 2022

eureciclo interfaces customer merchandise brands with recyclers, advancing reusing with social obligation. Through the eurecycle mark, we illuminate purchasers about organizations drew in with the environment,.encouraging more cognizant utilization. The eurecycle utilizes the natural pay model as an answer for invert planned operations. For this situation, natural pay comprises of discarding a mass of waste comparable to the mass of bundling that an organization puts available in an ecologically right way. For this, we endorse the administrators of assortment and arranging of recyclable waste and, through our mechanical stage, we really look at the consistency of the cycle in a versatile and safe manner. Then again, the connected with organizations produce motivations for the improvement of these administrators, demonstrate their interest in the reusing chain and, at last, get the eureciclo stamp to stamp their bundling and convey their obligation to buyers.

eureciclo has raised $19.6M across 1 round. Its most recent round was a Series B of $19.6M in Jun 2022. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Jun 14, 2022
Series B
$19.6M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

eureciclo is featured in

Similar companies

Movêu

Movêu is a digital furniture company that allows customers to create their own custom furniture using a user-friendly 3D customization tool.

Seed $550k
Mercado Único

Mercado Único is a business-to-business platform designed for managing the sale of near-expiration and slow-moving consumer goods at discounted prices, connecting suppliers with buyers who have immediate use for these items.

Pre-Seed $400k
Amicci

Amicci provides services to retail and industry to generate better sales, profits and consumer loyalty.

Series A $7.6M
Omens

Omens is a telehealth company dedicated to men's healthcare.

Seed $1.9M
Mirana Toys

Mirana Toys designs and develops toys for kids.

Series A $6.5M
TearSolutions

TearSolutions Inc. is a Delaware Corporation based in Charlottesville, VA. The company has successfully completed a well-powered 204 patient Phase II Proof of Concept clinical trial for the treatment of ocular surface disease in primary Sjögren’s Syndrome patients. Statistically significant improvement in both sign and symptom at two weeks was found. The trial compared vehicle and two doses of LacripepTM, a novel 19 AA peptide that is present in normal tears and deficient in all forms of dry eye. The peptide restores homeostasis to the ocular surface, in particular the barrier function of the corneal epithelium and normal function of sensory nerves at the corneal surface in preclinical animal models. Restoration of epithelial barrier function can be measured clinically as a decrease in corneal fluorescein staining while the improvement in sensory nerve function restores normal production of the components of tears: the aqueous via reinnervation of lacrimal glands, the lipid via reinnervation of meibomium glands and the mucin via reinnervation of goblet cells. Improvement in fluorescein staining and tear production (Schirmer tear test) are clinical ‘signs’ of ocular suface disease that have been used in the FDA approval of Xiidra and Restasis, respectively. Lacripep was discovered at the University of Virginia with NIH National Eye Institute funding as a naturally occurring fragment of the larger 119 AA protein, lacritin, in an unbiased screen for novel factors capable of addressing dry eye. Management team - CEO/President: Anil Asrani - Executive Chair: Robert Dempsey - CSO/Cofounder: Gordon W. Laurie PhD, FARVO - CFO: Colin M. Rolph - Chief Regulatory Officer: Michelle Carpenter JD, RAC - Chief Medical Officer: Marc G. Odrich, MD - Secretary: Mac Thompson, LLD For more information please visit www.tearsolutions.com

Venture - Series Unknown $520k
NORNORM

Imagine what humanity could achieve if millions of workspaces inspired people to do the best work of their lives. Now imagine what could happen if those spaces could evolve, in real time, to meet the aspirations of this work and the needs of the planet. At NORNORM, our ambition for today's workspaces is simple: integrate circularity into their foundation and demonstrate how it can benefit individuals, design, business practices and the environment. To start this, we created a subscription-based furnishing service based on an entirely circular business model. We provide businesses with workspace solutions that meet their needs as they change. From planning, to design, implementation and evaluation — we build spaces that eliminate unnecessary waste, adapt to all 'new normals' and are actually cost-conscious. Our mission is to make workspaces better — for the people they serve, the businesses they house and the planet they impact. All so you can focus on what really matters — creating the best work of your life.

Venture - Series Unknown $58.8M
Armoir

Armoir is a luxury luggage firm that designs quality suitcases inspired by another luggage brand.

Seed $500k
CUTISS

CUTISS AG has the capability to produce personalized human skin grafts, denovoSkin™, in bulk quantities using a small sample of healthy skin from the patient. The unique properties of denovoSkin™ are believed to lead to minimal scarring following transplantation. This product has received orphan drug designations from Swissmedic, EMA, and FDA for the treatment of burns.

Series C $38.9M
AgendaPro

AgendaPro is all-in-one web-based management platform for Aesthetic Clinics, Clinics, Salons, Barbershops, and, Spas in Latin America. The all-in-one platform allow our customers to manage online appointments, but also helps them with their cash management, inventory management , marketing campaigns, loyalty programs, and customer relationship management (CRM), so they can focus on giving the best service to their own customers.

Series B $35.0M
Big Potato Games

Big Potato is a board games company that's as versatile as its vegetable namesake.

Series Unknown $19.0M
Lifelong Online

Lifelong Online is a division of Lifelong Group, with more than 25 years of experience in industries such as Manufacturing, Luxury Travel, and Weddings & Event Management. Lifelong collaborates with top global brands in sectors including automotive, electrical, plastics, information technology, and medical.

Series Unknown $13.0M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.